Cytokinetics
Jonathan Kaltman is a distinguished medical professional with extensive experience in pediatric cardiology and clinical research. Currently serving as Senior Medical Director of Clinical Research Cardiovascular at Cytokinetics since June 2024, Kaltman previously held significant roles including Medical Director at BioMarin Pharmaceutical Inc. and Senior Scientific Advisor at the National Heart, Lung, and Blood Institute, where leadership in data science initiatives was a key responsibility. Kaltman's academic tenures include positions as Adjunct Professor and Assistant Professor at Children's National Hospital. Educational achievements include a Doctor of Medicine from Emory University School of Medicine and a Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University.
This person is not in any teams
This person is not in any offices
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.